Clinical validation:
ensuring safety and
credibility
AcuSurgical is committed to clinical excellence. Our first-in-human study confirms the safety, precision, and seamless integration of Luca in vitreoretinal surgery.
First-in-Human Study Completed Successfully
- In July 2024, AcuSurgical completed its first clinical trial using the Luca robotic surgical system for vitrectomy procedures.
- This marks a significant milestone in the evolution of robotic-assisted retinal surgery.
- Study conducted at Ghent University Hospital, Belgium
- Led by Dr. Fanny Nerinckx, Senior Vitreoretinal Surgeon
- Seven patients successfully treated with seamless integration of Luca into surgical workflow
- Demonstrated safety & efficacy in robotic-assisted vitrectomy